International Orthopaedics

, Volume 31, Issue 1, pp 133–134 | Cite as

HO prevention and the combined therapeutic protocol—do we really need it?

Letter to the editor


  1. 1.
    Ashton LA, Bruce W, Goldberg J, Walsh W (2000) Prevention of heterotopic bone formation in high risk patients post-total hip arthroplasty. J Orthop Surg (Hong Kong) 8(2):53–57Google Scholar
  2. 2.
    D’Lima DD, Venn-Watson EJ, Tripuraneni P, Colwell CW (2001) Indomethacin versus radiation therapy for heterotopic ossification after hip arthroplasty. Orthopedics 24(12):1139–1143PubMedGoogle Scholar
  3. 3.
    Handel M, Brettschneider J, Kock FX, Anders S, Perlick L, Sell S (2004) Risk factors associated with heterotopic ossifications in primary total hip arthroplasty. Z Orthop Ihre Grenzgeb 142(5):564–570PubMedCrossRefGoogle Scholar
  4. 4.
    Moed BR, Letournel E (1994 ) Low-dose irradiation and indomethacin prevent heterotopic ossification after acetabular fracture surgery. J Bone Joint Surg Br 76(6):895–900PubMedGoogle Scholar
  5. 5.
    Pakos EE, Pitouli EJ, Tsekeris PG, Papathanasopoulou V, Stafilas K, Xenakis TH (2006) Prevention of heterotopic ossification in high-risk patients with total hip arthroplasty: the experience of a combined therapeutic protocol. Int Orthop 30(2):79–83PubMedCrossRefGoogle Scholar
  6. 6.
    Zehetgruber H, Grubl A, Goll A, Schwameis E, Wurnig C, Giurea A (2005) Prevention of heterotopic ossification after THA with indomethacin: analysis of risk factors. Z Orthop Ihre Grenzgeb 143(6):631–637PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Kamil Cagri Kose
    • 1
    • 2
  • Oguz Cebesoy
    • 1
  • Levent Altinel
    • 1
  1. 1.Afyon Kocatepe University Faculty of MedicineDepartment of Orthopedics and TraumatologyAfyonTurkey
  2. 2.AfyonkarahisarTurkey

Personalised recommendations